hydroxychloroquine - Generic mfg.
Lupkynis (voclosporin) - Aurinia Pharmaceuticals
mycophenolate mofetil - Generic mfg.
A case of lupus nephritis achieving early remission using a treatment protocol similar to the AURORA trial with voclosporin and successfully discontinuing corticosteroids early. (PubMed, CEN Case Rep) - May 23, 2026 - "The patient was diagnosed with LN (ISN V) and started treatment with voclosporin combined with corticosteroids, hydroxychloroquine, and mycophenolate mofetil to decrease corticosteroids, which was similar to the regimen as in the AURORA study. Complete remission was achieved 30 days after treatment initiation, and the corticosteroids were discontinued 25 weeks after treatment initiation. This study represents the first clinical case report demonstrating complete remission of LN achieved by implementing the AURORA regimen." 
Journal • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease
http://www.ncbi.nlm.nih.gov/pubmed/42171925
 
Akira Mima; Keishi Matsumoto; Masasuke Kumagai; Sakura Kure; Shinji Lee; Shizuka Fukumoto; Takashi Hirata; Yuta Funabiki; Yuta Saito
 
May 23, 2026
 
Prev Next